CTE Share Price

Open 0.16 Change Price %
High 0.16 1 Day -0.02 -11.11
Low 0.16 1 Week -0.02 -11.11
Close 0.16 1 Month -0.03 -15.79
Volume 2000 1 Year -0.12 -42.86
52 Week High 0.26
52 Week Low 0.16
CTE Important Levels
Resistance 2 0.16
Resistance 1 0.16
Pivot 0.16
Support 1 0.16
Support 2 0.16
ASX Australia Most Active Stocks
AKK 0.01 0.00%
GPP 0.03 0.00%
IMU 0.01 0.00%
IMU 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
DUE 2.74 16.60%
DUE 2.74 16.60%
PDN 0.06 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AHN 0.04 100.00%
AZS 0.03 50.00%
AZS 0.03 50.00%
PMQ 0.03 50.00%
NGY 0.05 25.00%
BIT 0.05 25.00%
BIT 0.05 25.00%
RAW 0.06 20.00%
RAW 0.06 20.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
BMN 0.02 -33.33%
AZM 0.03 -25.00%
AZM 0.03 -25.00%
AZM 0.03 -25.00%
NMS 0.90 -23.73%
More..

Cryosite Ltd (ASX: CTE)

CTE Technical Analysis 5
As on 5th Dec 2016 CTE Share Price closed @ 0.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.32 & Strong Sell for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
CTE Target for December
1st Target up-side 0.2
2nd Target up-side 0.21
3rd Target up-side 0.22
1st Target down-side 0.18
2nd Target down-side 0.17
3rd Target down-side 0.16
CTE Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.cryosite.com
CTE Address
CTE
13a Ferndell Street
South Granville, NSW 2142
Australia
Phone: 61 2 8865 2000
Fax: 61 2 8865 2090
CTE Latest News
Interactive Technical Analysis Chart Cryosite Ltd ( CTE ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cryosite Ltd
CTE Business Profile
Cryosite Limited provides specialized outsourced biologistics-based services to clients in the clinical research, medical, pharmaceutical, veterinary, and biotechnology industries in Australia and New Zealand. It operates in two segments: Biological Services and Warehousing & Distribution Services. The Biological Services segment provides private cord blood, adult stem cell storage, and general biorepository management services. The Warehousing & Distribution Services segment offers clinical trials logistics services and the other distribution based services, including the importation and distribution of the products of the American Type Culture Collection and laboratory diagnostics products. The company was founded in 1999 and is based in South Granville, Australia.